EE200200139A - Hirudiini prekursor ja selle kasutamine, Leu-hirudiini valmistamismeetod, meetod sobiva signaalpeptiidi leidmiseks, hirudiini või hirudiini derivaadikasutamine ja meetod soovitud valgu valmistamiseks - Google Patents

Hirudiini prekursor ja selle kasutamine, Leu-hirudiini valmistamismeetod, meetod sobiva signaalpeptiidi leidmiseks, hirudiini või hirudiini derivaadikasutamine ja meetod soovitud valgu valmistamiseks

Info

Publication number
EE200200139A
EE200200139A EEP200200139A EEP200200139A EE200200139A EE 200200139 A EE200200139 A EE 200200139A EE P200200139 A EEP200200139 A EE P200200139A EE P200200139 A EEP200200139 A EE P200200139A EE 200200139 A EE200200139 A EE 200200139A
Authority
EE
Estonia
Prior art keywords
hirudin
leu
finding
producing
precursor
Prior art date
Application number
EEP200200139A
Other languages
English (en)
Inventor
Habermann Paul
Bender Rudolf
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200139A publication Critical patent/EE200200139A/et
Publication of EE05187B1 publication Critical patent/EE05187B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP200200139A 1999-09-18 2000-09-01 Hirudiini prekursor, selle kasutamine ja meetod Leu-hirudiini valmistamiseks EE05187B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944870A DE19944870A1 (de) 1999-09-18 1999-09-18 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
PCT/EP2000/008537 WO2001021662A1 (de) 1999-09-18 2000-09-01 Signalsequenzen zur herstellung von leu-hirudin über sekretion durch e. coli in das kulturmedium

Publications (2)

Publication Number Publication Date
EE200200139A true EE200200139A (et) 2003-06-16
EE05187B1 EE05187B1 (et) 2009-06-15

Family

ID=7922547

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200139A EE05187B1 (et) 1999-09-18 2000-09-01 Hirudiini prekursor, selle kasutamine ja meetod Leu-hirudiini valmistamiseks

Country Status (29)

Country Link
US (1) US7455987B1 (et)
EP (1) EP1216259B1 (et)
JP (1) JP4669181B2 (et)
KR (1) KR100737189B1 (et)
CN (2) CN1192037C (et)
AR (1) AR025660A1 (et)
AT (1) ATE357458T1 (et)
AU (1) AU775923B2 (et)
BR (1) BR0014519A (et)
CA (1) CA2385287C (et)
CZ (1) CZ2002899A3 (et)
DE (2) DE19944870A1 (et)
DK (1) DK1216259T3 (et)
EE (1) EE05187B1 (et)
HK (2) HK1049172A1 (et)
HR (1) HRP20020226B1 (et)
HU (1) HUP0202596A3 (et)
IL (2) IL148624A0 (et)
ME (1) MEP27908A (et)
MX (1) MXPA02002469A (et)
NO (1) NO329723B1 (et)
NZ (1) NZ517825A (et)
PL (1) PL205117B1 (et)
RS (1) RS50435B (et)
RU (1) RU2261867C2 (et)
SK (1) SK287865B6 (et)
TR (2) TR200200667T2 (et)
WO (1) WO2001021662A1 (et)
ZA (1) ZA200202106B (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
EP2314602A1 (en) 2003-11-21 2011-04-27 Pfenex, Inc. Improved expression systems with SEC-system secretion
AU2005269527B2 (en) 2004-07-26 2011-12-01 Pfenex Inc. Process for improved protein expression by strain engineering
DE102005046113A1 (de) * 2005-09-27 2007-03-29 Sanofi-Aventis Deutschland Gmbh Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen
DE102006044841A1 (de) 2006-09-22 2008-04-03 Wacker Chemie Ag Signalpeptid zur Produktion von rekombinanten Proteinen
AU2008210538B2 (en) 2007-01-31 2013-06-06 Pelican Technology Holdings, Inc. Bacterial leader sequences for increased expression
JP5444553B2 (ja) 2007-04-27 2014-03-19 フェネックス インコーポレイテッド 微生物宿主を迅速にスクリーニングして、異種タンパク質発現の収率および／または質が改善されている特定の株を同定する方法
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
ES2853935T3 (es) 2013-03-12 2021-09-20 Massachusetts Gen Hospital Proteínas modificadas de sustancia inhibidora muleriana (MIS) y usos de las mismas para el tratamiento de enfermedades
AU2014362307A1 (en) 2013-12-11 2016-06-30 The General Hospital Corporation Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation
CN108220369B (zh) * 2017-12-04 2021-03-12 广东双骏生物科技有限公司 一种生产重组水蛭素的方法
CN108359689B (zh) * 2018-01-19 2021-03-23 华中农业大学 利用抗病基因识别无毒效应蛋白以鉴定具有分泌功能信号肽的方法
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
FI96956C (fi) * 1985-04-11 1996-09-25 Hoechst Ag Menetelmä terapeuttisesti käyttökelpoisen hirudiinijohdannaisen valmistamiseksi
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
AU604925B2 (en) * 1988-02-23 1991-01-03 Schering Aktiengesellschaft A hirudin derivative
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
JPH07119237B2 (ja) * 1990-11-08 1995-12-20 株式会社ジャパンエナジー ヒルジン変異体，その製造法及び抗凝血剤
CA2255396A1 (en) * 1990-11-08 1992-05-09 Nippon Mining Company Limited Hirudin analog, method of manufacturing thereof and anti-coagulant composition, and secretion vector, transformed microorganisms containing said vector and manufacturing method ofproducts which is produced from said microorganism
PT100580A (pt) * 1991-06-12 1993-09-30 Regeneron Pharma Producao e recuperacao de neurotrofinas recombinantes
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
DE4140381A1 (de) 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet

Also Published As

Publication number Publication date
PL354444A1 (en) 2004-01-12
HUP0202596A3 (en) 2005-01-28
AR025660A1 (es) 2002-12-11
CN1550502A (zh) 2004-12-01
DE19944870A1 (de) 2001-03-29
RS50435B (sr) 2009-12-31
AU6842100A (en) 2001-04-24
ZA200202106B (en) 2003-01-09
DE50014189D1 (de) 2007-05-03
KR20020034188A (ko) 2002-05-08
WO2001021662A1 (de) 2001-03-29
CN1192037C (zh) 2005-03-09
AU775923B2 (en) 2004-08-19
BR0014519A (pt) 2002-06-11
MEP27908A (en) 2010-10-10
IL148624A (en) 2009-08-03
TR200501541T2 (tr) 2005-06-21
CN1374970A (zh) 2002-10-16
DK1216259T3 (da) 2007-07-02
CN1269838C (zh) 2006-08-16
HRP20020226B1 (en) 2010-08-31
HK1068352A1 (en) 2005-04-29
US7455987B1 (en) 2008-11-25
RU2261867C2 (ru) 2005-10-10
SK287865B6 (sk) 2012-02-03
ATE357458T1 (de) 2007-04-15
NO20021254L (no) 2002-05-07
KR100737189B1 (ko) 2007-07-10
JP2003510041A (ja) 2003-03-18
IL148624A0 (en) 2002-09-12
CA2385287A1 (en) 2001-03-29
NZ517825A (en) 2004-07-30
YU14602A (sh) 2005-07-19
NO20021254D0 (no) 2002-03-13
JP4669181B2 (ja) 2011-04-13
CA2385287C (en) 2010-10-19
HRP20020226A2 (en) 2004-04-30
EP1216259A1 (de) 2002-06-26
MXPA02002469A (es) 2002-08-28
EP1216259B1 (de) 2007-03-21
TR200200667T2 (tr) 2002-06-21
HUP0202596A2 (hu) 2002-12-28
RU2002110278A (ru) 2004-03-27
PL205117B1 (pl) 2010-03-31
SK3622002A3 (en) 2003-06-03
EE05187B1 (et) 2009-06-15
CZ2002899A3 (cs) 2002-06-12
NO329723B1 (no) 2010-12-06
HK1049172A1 (en) 2003-05-02

Similar Documents

Publication Publication Date Title
EE200200139A (et) Hirudiini prekursor ja selle kasutamine, Leu-hirudiini valmistamismeetod, meetod sobiva signaalpeptiidi leidmiseks, hirudiini või hirudiini derivaadikasutamine ja meetod soovitud valgu valmistamiseks
AU6099100A (en) Ultra-rugged i.c. sensor and method of making the same
AU2001232799A1 (en) Protein c derivatives
ITRM20000228A0 (it) Scidula multistrato e procedimento per la sua produzione.
BR0010659B1 (pt) mÉtodo para a fabricaÇço de artigo absorvente tendo recurso de fixaÇço com pequena auto-adesço.
EE03482B1 (et) Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine
AU2001241068A1 (en) Indole derivatives, process for preparation of the same and use thereof
NO961006D0 (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
EE04485B1 (et) Kihttarindi element, selle valmistamismeetod ja kasutamine
NO20030844D0 (no) Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
AU2001262221A1 (en) Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
EE04902B1 (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
AU6218900A (en) Disposable absorbent article employing an absorbent composite, and method of making the same
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
AU2002259316A1 (en) Protein arrays and methods and systems for producing the same
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
AU4188500A (en) Protein c derivatives
AU2452301A (en) Protein methylarginine-specific antibodies
EE200200096A (et) IREN-valk, selle valmistamine ja kasutamine
AU1751801A (en) Protein c derivatives
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
EE04837B1 (et) Ehhinokandiini derivaadid, nende valmistamismeetod ja kasutamine antimükootikumidena
AU1855001A (en) A new member of the pak protein family, nucleic acids and methods related to thesame
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20120901